Biogen
BIIB
BIIB
912 hedge funds and large institutions have $25.1B invested in Biogen in 2024 Q3 according to their latest regulatory filings, with 99 funds opening new positions, 268 increasing their positions, 376 reducing their positions, and 117 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
24% less call options, than puts
Call options by funds: $214M | Put options by funds: $282M
29% less repeat investments, than reductions
Existing positions increased: 268 | Existing positions reduced: 376
33% less funds holding in top 10
Funds holding in top 10: 12 → 8 (-4)
Holders
912
Holding in Top 10
8
Calls
$214M
Puts
$282M
Top Buyers
| 1 | +$169M | |
| 2 | +$167M | |
| 3 | +$113M | |
| 4 |
Barclays
London,
United Kingdom
|
+$99.1M |
| 5 |
Two Sigma Investments
New York
|
+$91.2M |
Top Sellers
| 1 | -$298M | |
| 2 | -$181M | |
| 3 | -$172M | |
| 4 |
SCM
Sarissa Capital Management
Greenwich,
Connecticut
|
-$129M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$126M |